News for Healthier Living

Bleeding Risk with Apixaban and Dabigatran Similar to Aspirin

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found that rates of major bleeding for therapeutic-dose apixaban and dabigatran were similar to low-dose aspirin, but rates were higher for rivaroxaban.

February 10, 2025


February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025

February 7 2025

February 6 2025

February 5 2025

February 4 2025

February 3 2025

February 2 2025

February 1 2025

January 31 2025

January 30 2025

January 29 2025